Legend Capital

Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Angitia Biopharmaceuticals is a global clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases, specifically targeting bone, muscle, and joint conditions. Through its research and development activities, it aims to deliver breakthrough therapies that address unmet needs and improve outcomes for patients with severe musculoskeletal disorders.

Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.

DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.

Angitia Biopharmaceuticals is a global clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases, specifically targeting bone, muscle, and joint conditions. Through its research and development activities, it aims to deliver breakthrough therapies that address unmet needs and improve outcomes for patients with severe musculoskeletal disorders.

Rxilient Health is a company that specializes in providing contract development and manufacturing organization (CDMO) services for the pharmaceutical industry. It focuses on manufacturing and distributing pharmaceutical products designed to address unmet medical needs as well as health and beauty requirements. The company offers a diverse range of professional dermatology and medical aesthetic products, emphasizing a scientific approach to skin health and aesthetics. This enables Rxilient Health to cater to a wide array of consumer demands in the realm of skincare and cosmetic solutions.

Ligatech Bioscience, established in 2014 and headquartered in Qingpu, China, specializes in the design, development, production, and sales of medical devices for orthopedic and sports medicine. Its product portfolio includes molecular weight polyethylene suture and striped titanium plates, along with artificial ligaments and fixation systems. The company also offers technical advice and services to its users.

HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

Boyin Hearing offers a comprehensive selection of hearing treatments for persons suffering from hearing loss.

CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.

Bio-Engine is a company based in Shanghai, China, focused on the research and development of veterinary biological products. Founded in 2014, Bio-Engine specializes in creating and producing antibodies, recombinant proteins, and vaccines for both humans and livestock using serum-free suspension culture technology for animal cells. The company's expertise extends to providing clinical trial services for pharmaceutical manufacturers and scientific research units.

TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

N1 Life is a biomedical company dedicated to drug discovery and the development of innovative therapeutics, particularly focusing on PDC drugs within the anti-tumor pipeline. The company aims to bridge the gap between research and clinical application by employing advanced drug delivery technologies. By leveraging disruptive innovations, N1 Life strives to transform the pharmaceutical industry, significantly reducing both the cost and timeline associated with drug development. This approach enables the healthcare sector to better address the unmet medical needs of both humans and companion animals.

Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Life Biosciences specializes in animal behaviour analysis services, supporting scientific research with a comprehensive suite of offerings including blood biochemistry tests, routine blood examinations, pathological staining, immunohistochemistry, molecular and cellular experiments, flow cytometry, X-ray irradiation, and nuclear magnetic resonance imaging. They also provide experimental animal model resources, large animal disease models, testing, imaging, foster care, decontamination services, further facilitating laboratory animal research within the scientific community.

ClinBrain is a company that focuses on healthcare big data services, specifically aimed at hospitals. It has developed a hospital information integration platform that digitizes and standardizes patient data alongside medical and clinical data. This integration is designed to facilitate medical research, improving the efficiency and effectiveness of data management in healthcare settings. By streamlining access to comprehensive patient information, ClinBrain aims to enhance the overall quality of medical research and healthcare delivery.

Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

MediLink Therapeutics is a China-based developer of antibody-drug conjugates (ADC) focused on cancer therapy. The company advances next-generation ADCs and aims to address unmet medical needs in China, while pursuing global value through multicenter clinical trials and cross-border collaborations. Its R&D center is in Suzhou.

Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.

Singlomics is a biotechnology company that leverages single-cell sequencing technology to develop innovative antibody drugs aimed at treating infectious diseases and cancers. The company focuses on the discovery and development of neutralizing antibodies, including DXP593 and DXP604, which serve as potential therapeutic solutions against COVID-19. By utilizing advanced sequencing techniques, Singlomics aims to enhance the efficacy of antibody treatments and address significant health challenges in infectious diseases and oncology.

Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

LePure Biotech, established in 2011 and headquartered in Shanghai, China, operates within the biotechnology and pharmaceutical sectors. The company specializes in the development and manufacturing of disposable biopharmaceutical process equipment and consumables, primarily focusing on products that facilitate the storage, transportation, filling, and leak detection of samples related to biosimilars, vaccines, and other biopharmaceutical applications. Its core offering is a disposable storage bag designed to meet the specific needs of these processes. Recently, LePure Biotech completed a B+ round of financing, which aims to fund the development of innovative products, establish a research and development center in the United States, enhance supply chain integration, and expand its R&D operations both domestically and internationally.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, founded in 2009. The company specializes in providing research and development services to facilitate drug discovery. Its offerings include recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus operates five advanced research platforms, including X-ray crystallography and cryo-electron microscopy, aimed at delivering high-quality R&D services to clients. The organization is known for its innovative approaches, with several techniques developed by its research team receiving patents. Wuxi Biortus is a subsidiary of Jiangsu Shuangliang Group Company Ltd.

HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

BioMap, founded in 2020 by Robin Li and Wei Liu, is an innovative life science AI company that has developed xTrimo, the largest protein-centric large language model platform. The company's technology enables scientists to model biological processes with greater accuracy, focusing on proteins and extending to system-level interactions. By leveraging limited data, BioMap facilitates the extraction of novel insights and predictions, addressing significant challenges in protein-related drug development. With a diverse team of over 300 experts, BioMap aims to enhance the effectiveness of new drugs, ultimately striving to improve patient outcomes in the healthcare sector.

Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Varnotech is a biotechnology company founded in 2019 that focuses on the development of vaccines, antibodies, and adjuvants aimed at combating various diseases and viruses. The company is dedicated to creating effective human vaccines and innovative adjuvants to enhance immune responses, thereby improving patient outcomes. Through its research and development efforts, Varnotech aims to address significant health challenges and contribute to global public health initiatives.

Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company that focuses on the development and commercialization of protein and peptide-based drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company targets multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neurodegenerative disorders. Sciwind's innovative drug candidates are particularly designed to address metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for physicians and their patients.

Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Founded in 2007, MicuRx Pharmaceuticals discovers and develops novel antibiotics to combat drug-resistant bacterial infections. Its pipeline includes MRX-I, an oral antibiotic for gram-positive infections, MRX-IV for intravenous use, MRX-V for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company operates under a hybrid U.S./China business model.

Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.

Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Novast is a multinational pharmaceutical company focused on the research, development, and manufacture of value-added and complex dosage forms, including controlled-release and other advanced drug-delivery systems. With operations in China and the United States, it partners with pharmaceutical and biotechnology companies to develop and commercialize products for regulated markets, providing product development services and leveraging proprietary technologies. The company emphasizes designing formulations for challenging APIs and global markets, supported by cGMP manufacturing capabilities and quality systems. It also engages in contract research, development, and quality control to support clients in achieving regulatory approval and efficient market access. Through its drug-delivery platforms and comprehensive development capabilities, Novast aims to improve access to affordable, high-quality medications while expanding its international footprint.

Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Suzhou Ribo Life Science focuses on developing nucleic acid therapeutics using RNA interference (RNAi) technology. The company advances RNAi-based drug discovery, including siRNA design and screening, chemical modification and delivery technologies, and pharmacokinetic and safety evaluation, through to clinical trials. It targets liver-related diseases, including Hepatitis B, liver fibrosis and liver cancer, as well as breast cancer and HIV. The company operates from Kunshan, China, and was founded in 2007. It has pursued strategic partnerships, notably with Quark Pharmaceuticals, to advance its RNAi programs.

Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.

Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company that focuses on the development and commercialization of protein and peptide-based drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company targets multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neurodegenerative disorders. Sciwind's innovative drug candidates are particularly designed to address metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for physicians and their patients.

Shanghai Tenry Pharmaceutical Company Limited (Tenry) is a modern pharmaceutical enterprise based in Shanghai, specializing in the development and production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company operates two advanced manufacturing plants and has achieved approval for 73 national drugs, including two biological agents. Tenry's primary focus includes research and development, sales and marketing, and regulatory compliance, allowing it to provide innovative treatments for patients. Its leading products address critical needs in bleeding management and wound management, positioning Tenry as a significant player in the pharmaceutical industry.

Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.

SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Urotronic Inc., established in 2014 and headquartered in Plymouth, Minnesota, specializes in developing and manufacturing medical devices for urological applications. The company's primary product is Optilume, a Drug Coated Balloon (DCB) catheter designed to treat urethral strictures in men by dilating the blocked area and delivering a drug that prevents scar tissue formation. This minimally invasive procedure reduces patient discomfort and recovery time compared to traditional surgical methods. Urotronic serves both urologists and patients, aiming to improve treatment outcomes for urinary tract conditions.

China Diagnostic Medical Corporation is a diagnostic testing reagents maker.

Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.

Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

DEEP Informatics is a smart AI medical treatment and imaging company.

Enjoy Dental Clinic is a prominent dental care provider established in 2007 and headquartered in Beijing, China. This large-scale dental chain integrates medical treatment with scientific research, education, and administrative functions. The clinic is committed to standardized practices for oral safety, utilizing a four-hand operation model and a rigorous "one person, one machine" aseptic disinfection protocol. Enjoy Dental Clinic employs advanced technologies, including 3D printing, digital-guided dental implants, ultra-thin cosmetic dentistry, and oral digital CT scanning, which enhance treatment efficacy and patient satisfaction. Additionally, the clinic offers franchising services, providing aspiring dentists with professional training and practical experience in clinic management.

Puyi Biotechnology is a company focused on the high-value medical device market, with a specialization in material science and drug delivery technology. It has established a distinctive presence in several medical fields, including ear, nose, and throat (ENT) care, reproductive health, and medical aesthetics. The company develops minimally-invasive implanted medical devices designed for healthcare professionals, particularly emphasizing degradable, drug-releasing sinus stents that enhance patient outcomes following surgery. Through its innovative approach, Puyi Biotechnology aims to improve treatment efficacy and patient recovery in various medical applications.

Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.

Yosemite Clinic is a comprehensive medical facility located in Central Pudong, Shanghai, offering a wide range of walk-in medical services. The clinic specializes in various fields, including family and internal medicine, surgery, orthopedics, dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, and rehabilitation medicine. Equipped with advanced technology, Yosemite Clinic features state-of-the-art facilities such as CT, X-ray, ultrasound, and operating rooms, ensuring high-quality care. The clinic's diverse team of medical professionals, hailing from both China and around the globe, allows it to provide services in multiple languages, including English, Japanese, Malay, Mandarin Chinese, and Cantonese. By combining a multidisciplinary approach with modern medical practices, Yosemite Clinic aims to meet the diverse healthcare needs of its patients effectively.

Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

Ayshealth Technology, founded in 2014 and based in Beijing, China, specializes in developing chronic disease management systems. The company offers a guideline-based decision support (GDS) platform that utilizes artificial intelligence technologies to assist healthcare providers in diagnosing and treating chronic diseases. This cloud-based service enables physicians, patients, hospital administrators, government agencies, and insurance companies to effectively monitor and manage health data related to chronic conditions. By providing data analytics and professional medical support, Ayshealth Technology enhances decision-making capabilities for doctors and facilitates comprehensive patient care.

ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

PhiSkin is a skin and laser clinic based in China that specializes in aesthetic medicine. The company offers a range of services including aesthetic product injections, such as Botox and hyaluronic acid, laser treatments, double eyelid surgery, and various non-surgical beauty procedures. PhiSkin aims to provide customers with a thorough understanding of their skin conditions while delivering tailored skincare solutions to meet individual needs.

Axonics Modulation Technologies, Inc. is a medical technology company focused on the development and commercialization of sacral neuromodulation (SNM) systems, catering to both domestic and international markets. The company’s SNM systems are designed to address conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. Its innovative rechargeable SNM System delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder and bowel to alleviate associated symptoms. Originally incorporated as American Restorative Medicine, Inc. in 2012, the company rebranded as Axonics Modulation Technologies, Inc. in August 2013 and is headquartered in Irvine, California.

Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.

POCTech Medical develops a CGM sensor product for the diabetes care communities.

Suzhou Ribo Life Science focuses on developing nucleic acid therapeutics using RNA interference (RNAi) technology. The company advances RNAi-based drug discovery, including siRNA design and screening, chemical modification and delivery technologies, and pharmacokinetic and safety evaluation, through to clinical trials. It targets liver-related diseases, including Hepatitis B, liver fibrosis and liver cancer, as well as breast cancer and HIV. The company operates from Kunshan, China, and was founded in 2007. It has pursued strategic partnerships, notably with Quark Pharmaceuticals, to advance its RNAi programs.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.

PegBio is a biopharmaceutical company based in Suzhou, focused on polyethylene glycol (PEG) chemistry and PEGylation technology to develop and manufacture PEGylated drugs as potential new molecule entities. The company offers PEG synthesis and PEGylation services, including N-terminal specific, thiol-selective, and enzymatic PEGylation, along with pharmaceutical-grade PEGs and activated PEGs for research and pharmaceutical applications. It provides PEGylation services to universities, research institutes, and pharmaceutical companies and develops PEGylated peptides and antibody fragments for therapeutic areas such as type II diabetes and rheumatoid arthritis. PegBio also develops PB-119, a glucagon-like peptide-1 (GLP-1) receptor agonist designed for less frequent dosing, and engages in collaborations with strategic partners to modify macromolecules and advance PEGylated biopharmaceuticals.

Shanghai Neuromedical Center is a specialized neurology clinic dedicated to advancing functional neurosurgery and providing comprehensive care in areas such as neurosurgery, neurology, neurorehabilitation, neuropsychology, and emergency critical care medicine. The center focuses on delivering expert treatment for conditions such as brain tumors and epilepsy, ensuring that patients receive high-quality, specialized care. By integrating clinical practice with scientific research and education, Shanghai Neuromedical Center aims to enhance patient outcomes and contribute to the evolution of neurosurgical techniques and methodologies.

Hisky Medical is a company based in Beijing, China, established in 2010, that specializes in the development, manufacturing, and marketing of medical equipment aimed at non-invasive liver diagnosis. The firm focuses on innovative technologies for disease diagnosis and has developed a product called FibroTouch, which is designed to facilitate the assessment of liver conditions without the need for invasive procedures. Through its advancements in medical technology, Hisky Medical aims to improve diagnostic accuracy and patient comfort in the evaluation of liver health.

Unimed Technology operates an Internet-based medical services platform that integrates medical resources for various stakeholders, including medical institutions, doctors, and patients. The company is focused on enhancing the efficiency of healthcare delivery by enabling doctors to treat patients and conduct follow-up care and research seamlessly. Unimed's platform also offers customized services specifically tailored for patients with chronic diseases, ensuring comprehensive support throughout the treatment process. This integrated approach aims to improve patient outcomes and streamline medical practices.

Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.

Insurengine offers health insurance services including home care, hospital escort, and other services. They also offer medical examination services such as respiratory, cardiovascular, and cerebrovascular systems and general physical examinations.

Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.

Axonics Modulation Technologies, Inc. is a medical technology company focused on the development and commercialization of sacral neuromodulation (SNM) systems, catering to both domestic and international markets. The company’s SNM systems are designed to address conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. Its innovative rechargeable SNM System delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder and bowel to alleviate associated symptoms. Originally incorporated as American Restorative Medicine, Inc. in 2012, the company rebranded as Axonics Modulation Technologies, Inc. in August 2013 and is headquartered in Irvine, California.

Audoline is a hearing healthcare platform. They provide hearing medical services. They also provide a cochlear implant, a hearing aid, bone anchored hearing aids, and hearing accessories.

Noitom is a 3D motion measurement and motion capture technology company. They offer business covering digital media technology, digital orthopedic medical equipment, and intelligent medical and physical integration applications.

ET Healthcare is a medical diagnostics company focused on automated immunodiagnostics. It develops central laboratory analyzers and near-patient testing solutions, with the Pylon Immunochemistry System designed to bring immunoassay performance closer to point-of-care. The system integrates central laboratory capabilities for immunoassays addressing inflammation, cardiac function, fertility, infectious diseases, and tumors, and includes BNP Immunoassay for heart failure management. The company operates from Palo Alto, California, with offices in Shanghai and manufacturing facilities in Suzhou, China. Its products aim to reduce facility space, plumbing, electricity needs, and staffing requirements while enabling high-sensitivity assays and streamlined blood analysis for a range of clinical settings, including hospitals and clinics.

Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Percans Oncology is a biotechnology company dedicated to advancing personalized cancer treatments. They specialize in developing individualized treatment plans by offering services such as cross-indication drug combination solutions, vitro susceptibility testing, and a tumor cell drug sensitivity detection kit. Their focus lies in creating innovative cancer-specific drug products centered around synthetic lethality and immunotherapy, aiming to enhance the effectiveness of each patient's treatment plan and extend lives.

Unimed Technology operates an Internet-based medical services platform that integrates medical resources for various stakeholders, including medical institutions, doctors, and patients. The company is focused on enhancing the efficiency of healthcare delivery by enabling doctors to treat patients and conduct follow-up care and research seamlessly. Unimed's platform also offers customized services specifically tailored for patients with chronic diseases, ensuring comprehensive support throughout the treatment process. This integrated approach aims to improve patient outcomes and streamline medical practices.

Innovent Biologics is a China-based biopharmaceutical company that discovers, develops, manufactures, and commercializes monoclonal antibodies. It operates a platform for antibody therapeutics across oncology, ophthalmology, immunology, and metabolic diseases, with Tyvyt (sintilimab) as its core asset, a PD-1 inhibitor used in first-line and other cancer indications. The company develops a broad pipeline including biosimilars and novel antibodies and provides distribution, consulting, and R&D services. It maintains strategic collaborations with global partners, including a co-development arrangement with MD Anderson Cancer Center and an alliance with Eli Lilly for TYVYT, and has more than 30 collaborations with major pharmaceutical companies. Innovent is listed on the Hong Kong Exchange and maintains manufacturing and development capabilities in China with a growing portfolio of oncology and non-oncology products marketed domestically and internationally.

POCTech Medical develops a CGM sensor product for the diabetes care communities.